A patient with progressive myoclonus epilepsy and Lafora bodies in the central nervous system also has a material with staining properties similar to polyglucosans in other organs. This suggests that Lafora disease is a glycometabolic disorder (Harriman et al. 1955) .
Liver biopsy (Inoue et al. 1974; Nishimura et al. 1980) , muscle biopsy (Carpenter et al. 1974 ) and skin biopsy (Carpenter et al. 1981) are useful in the diagnosis of Lafora disease. Familial cases of Lafora disease diagnosed by liver biopsy have been reported (Inoue et al. 1974 Liver Biopsy A section of the liver biopsy specimen had a pale basophilic material that stained with Hematoxylin-Eosin (H-E) . A PAS-positive substance that resisted diastase digestion was clearly identified in the cytoplasm of liver cells, these observations made the diagnosis of Lafora disease possible (Fig.2) .
15 years after the onset of symptoms, the patient died of pneumonia.
Finding at Autopsy
Only the brain and liver were observed. The brain, macroscopically, was normal except for a slight edema.
It was, however, noticed with histological examination that Lafora bodies were diffusely found in many regions of the brain, although the distribution density was different.
Only the internal portions of Lafora bodies were basophilic.
It contained a strongly PAS-positive substance, whereas the external portion was weakly PAS-positive (Fig.3) . As shown in (Fig.  4) , the histological findings of the liver were similar to the result of biopsy. The concentrations of the glycosaminoglycan and glycoprotein in the urine obtained before death were not significantly different from normal (Inoue, 1983) . EEG with an atypical spike and wave complex or polyspike and wave complex. 
